missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD4 Monoclonal Antibody (OTI2A7), TrueMAB™, OriGene
Mouse Monoclonal Antibody
Brand: Origene Technologies TA800561S
This item is not returnable.
View return policy
Description
CD4 Monoclonal antibody specifically detects CD4 in Canine, Human samples. It is validated for Western BlotSpecifications
| CD4 | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
| Q567U6 | |
| Mouse | |
| Affinity chromatography | |
| RUO | |
| 476119, 54520 | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| IgG1 |
| Western Blot | |
| OTI2A7 | |
| Unconjugated | |
| CCDC93 | |
| Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen | |
| Human recombinant protein fragment corresponding to amino acids 293-631 of human CCDC93 produced in E.coli. | |
| 30 μL | |
| Primary | |
| Canine, Human | |
| Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction